Home Health Care News October 30, 2019
With a number of upcoming regulatory changes sure to shake up the home health industry — including the Patient-Driven Groupings Model (PDGM), the Review Choice Demonstration (RCD) and a phaseout of Requests for Anticipated Payments (RAPs) — a provider’s future isn’t exactly clear.
As a result, questions surrounding how and when to best approach mergers-and-acquisitions opportunities loom large.
While that’s particularly true for home health providers, it’s a concept that applies to hospice and home care operations as well. Hospice and home care have both been hot M&A targets for many buyers, meaning the time may never be better to sell.